Advent International To Buy Stakes In Suven Pharma
Global Private Equity Investor Advent International announced on Monday that it is acquiring a 50.1 Per cent stake in Suven Pharmaceuticals for Rs. 6,313 crores and was planning to merge with its portfolio company Cohance Lifescience. The promoter Jasti family will hold a 9.9 per cent stake in the firm if the deal gets done.  …
Shipra Prajapati